Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5281851
Max Phase: Preclinical
Molecular Formula: C34H48N4O10S
Molecular Weight: 704.84
Associated Items:
ID: ALA5281851
Max Phase: Preclinical
Molecular Formula: C34H48N4O10S
Molecular Weight: 704.84
Associated Items:
Canonical SMILES: CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(NC(=O)CNC(=O)OC(C)(C)C)cc1
Standard InChI: InChI=1S/C34H48N4O10S/c1-22(2)19-38(49(43,44)25-13-11-24(12-14-25)36-30(40)18-35-32(41)48-34(3,4)5)20-28(39)27(17-23-9-7-6-8-10-23)37-33(42)47-29-21-46-31-26(29)15-16-45-31/h6-14,22,26-29,31,39H,15-21H2,1-5H3,(H,35,41)(H,36,40)(H,37,42)/t26-,27-,28+,29-,31+/m0/s1
Standard InChI Key: SCVXZOOPDYIXHB-SQQOACJHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 704.84 | Molecular Weight (Monoisotopic): 704.3091 | AlogP: 3.26 | #Rotatable Bonds: 14 |
Polar Surface Area: 181.83 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 14 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.39 | CX Basic pKa: | CX LogP: 3.45 | CX LogD: 3.45 |
Aromatic Rings: 2 | Heavy Atoms: 49 | QED Weighted: 0.23 | Np Likeness Score: -0.39 |
1. Ghosh AK, Shahabi D, Kipfmiller M, Ghosh AK, Johnson M, Wang YF, Agniswamy J, Amano M, Weber IT, Mitsuya H.. (2023) Evaluation of darunavir-derived HIV-1 protease inhibitors incorporating P2' amide-derivatives: Synthesis, biological evaluation and structural studies., 83 [PMID:36738797] [10.1016/j.bmcl.2023.129168] |
Source(1):